ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

In Brief: NCAB Committee Recommends Joint NCI/Vendor PDQ Promotion; Frank Schabel Dies In Vienna

September 9, 1983

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

DCT Board Ok’s Grants Program For AIDS Malignancies, Contracts

October 23, 1992